Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for atherosclerosis progression in patients with lupus.
Anti-TFAM antibodies are detected in about one third of patients with systemic lupus erythematosus and are associated with a threefold higher risk for thrombotic events.
The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it’s ‘good science, good ethics, and good business,’ one expert said.
A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and the risk for posttraumatic osteoarthritis.
Despite an increased risk for complications and death in men after fractures, the US Preventive Services Task Force maintains there’s insufficient evidence to recommend osteoporosis screening for men.